Title:
【発明の名称】新規ワクチン
Document Type and Number:
Japanese Patent JP2003509451
Kind Code:
A
Abstract:
The invention relates to the use of a non-live influenza virus antigen preparation, particularly a split influenza virus preparation, in the manufacture of a vaccine formulation for a one-dose intranasal vaccination against influenza, wherein the one-dose vaccination meets international regulatory requirements for influenza vaccines. Further provided are methods for the production of the vaccine, and a pharmaceutical kit comprising an intranasal administration device and the one-dose vaccine.
Inventors:
Fried, Martin
Anderick, Veronic
Elman, Philip
Slaui, Moncef Moam
Toran, Stephen Gabriel Joseph
Anderick, Veronic
Elman, Philip
Slaui, Moncef Moam
Toran, Stephen Gabriel Joseph
Application Number:
JP2001524577A
Publication Date:
March 11, 2003
Filing Date:
September 22, 2000
Export Citation:
Assignee:
Smith Klein Beacham Biologicals Society Anonymous
International Classes:
A61K9/00; A61K39/145; A61K39/39; A61K47/10; A61K47/14; A61K47/28; A61K47/36; A61K47/08; A61P31/16; (IPC1-7): A61K39/145; A61K47/08; A61K47/10; A61K47/14; A61K47/28; A61K47/36; A61P31/16
Domestic Patent References:
JPH09508614A | 1997-09-02 | |||
JPS62281813A | 1987-12-07 | |||
JPH08506592A | 1996-07-16 |
Other References:
JPN6010047760, Vaccine Research, 1996, Vol.5, No.2, p.69−75
Attorney, Agent or Firm:
Takashi Ishida (4 others)